Atinary
Atinary is a Swiss-American deeptech company founded in 2019 that builds the SDLabs no-code AI platform and physical Self-Driving Labs integrating Bayesian optimization with robotics, serving pharmaceutical, biotech, chemicals, and materials R&D teams through enterprise SaaS subscriptions and managed lab services.
- Company typePrivate
- Founded2019
- HeadquartersLausanne, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Atinary does
Atinary is a Swiss-American deeptech company founded in 2019 by Harvard PhDs Dr. Hermann Tribukait (CEO) and Dr. Loïc Roch (CTO), headquartered at the Biopôle life-sciences campus in Epalinges/Lausanne, Switzerland with a US corporate base in Menlo Park, Delaware, and a Self-Driving Lab in Boston's Kendall Square. The company has built the SDLabs AI Platform — a no-code, cloud-hosted agentic AI platform that integrates proprietary Bayesian Optimization algorithms, the SeMOpt transfer-learning module, and the Falcon multi-objective optimizer for solving complex chemistry, materials, and pharmaceutical R&D problems — and pairs it with physical Self-Driving Labs that integrate robotics from ABB, Agilent, Bruker, Chemspeed, and Mettler-Toledo into closed-loop Design-Make-Test-Analyze-Learn cycles capable of running 200–400 experiments per day.
The platform serves pharmaceutical, biotechnology, chemicals, materials, cosmetics, energy, and agri-food customers, with flagship enterprise relationships including Takeda (drug development), Snapdragon Chemistry / Cambrex (oligonucleotide synthesis), dsm-firmenich (hydroformylation catalyst optimization), IBM Research Europe (RoboRXN integration), Solaronix, and academic collaborations with ETH Zurich, MIT, Stanford, and DTU. The company has demonstrated validated outcomes including 5x–100x reductions in development time versus DOE/OFAT, a 1000x acceleration in CO2-to-methanol catalyst discovery with ETH, and 95–97% cost reductions in Rhodium catalyst loading for dsm-firmenich.
Atinary monetizes through annual SDLabs SaaS subscriptions complemented by multi-year Self-Driving Lab managed-service contracts delivered via direct enterprise field sales, with SOC-2 Type II, HIPAA, and GDPR compliance hosted on AWS. Total disclosed funding is approximately $7M equivalent ($5M seed led by AgFunder in September 2023 plus a CHF 2M Innosuisse grant in April 2023), supporting a 16-person team across 13 nationalities. Recognition includes the 2026 World Economic Forum Technology Pioneer designation, Forbes 30Under30 (2025), and the Solar Impulse Efficient Solution Label (2022).
Atinary firmographics
Firmographics- Name
- Atinary
- Legal name
- Atinary Technologies, Inc.
- Website
- https://atinary.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Atinary is a Swiss-American deeptech company founded in 2019 that builds the SDLabs no-code AI platform and physical Self-Driving Labs integrating Bayesian optimization with robotics, serving pharmaceutical, biotech, chemicals, and materials R&D teams through enterprise SaaS subscriptions and managed lab services.
- Ownership category
- akta.pro rank
Atinary industry classification
Industry- Product category
- AI-driven R&D platform for chemistry, materials, and pharmaceutical discovery
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (5415), Computer Systems Design Services (541512), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)
- akta.pro secondary industries
- AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ), Model Deployment, Serving & Inference Platforms (HDAAABAF)
Keywords
Where Atinary is headquartered
LocationHeadquarters
- HQ city
- Lausanne
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Atinary business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: Annual subscription model for access to SDLabs AI platform and Self-Driving Labs technology. Includes onboarding, support, and enterprise-grade security (SOC-2, HIPAA, GDPR compliance).
- Self-Driving Lab Services: Fully integrated production-grade Self-Driving Lab platform combining AI, robotics, automation, and precision instrumentation. Delivered as a service with full integration into customer workflows.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription with full platform access |
| Hybrid | Multi-year contract | Self-Driving Lab deployment |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Atinary product offering
Product offeringCore offering
Atinary develops and sells the SDLabs AI Platform, a cloud-based no-code software that combines Bayesian optimization machine learning, transfer-learning algorithms (SeMOpt, Falcon), data analytics, and visualization to solve multi-objective optimization problems in chemistry, materials, and pharmaceutical R&D. The company also delivers Self-Driving Labs, a fully integrated autonomous laboratory system combining AI, robotics (ABB, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise to execute closed-loop Design-Make-Test-Analyze-Learn cycles. Customers access the platform via enterprise annual subscriptions, with deployment in under two hours.
Product overview
Atinary offers a unified AI-driven R&D platform centered on the SDLabs AI Platform and Self-Driving Labs technology. The SDLabs platform provides a code-free interface for Bayesian Optimization and multi-objective optimization, while the Self-Driving Labs deliver fully integrated autonomous laboratory capabilities. Key components include the SeMOpt transfer-learning algorithm for knowledge reuse across experiments and the Falcon optimizer for specific discovery applications. The platform serves pharma, biotech, chemicals, cosmetics, and energy industries with solutions for formulation, catalysis, and synthesis optimization.
Differentiator
Problem solved
Functional benefit
Brands
- SDLabs: Atinary's no-code AI platform for accelerated optimization and discovery of molecules and materials
- Self-Driving Labs
- SeMOpt
- Nexus
Products and services
- SDLabs AI Platform Cloud-based, code-free, agentic AI platform integrating machine learning optimizers, data analytics, and visualization into a single intuitive interface. Enables scientists without programming or AI expertise to solve complex multi-objective optimization challenges in chemistry, materials, and pharmaceutical R&D. Deploys in under two hours and integrates with existing workflows, LIMS, ELN, and optional robotic hardware.
- Self-Driving Labs Fully integrated autonomous laboratory technology that combines AI, robotics (ABB GoFa cobots, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise into a unified closed-loop ecosystem. Executes Design-Make-Test-Analyze-Learn (DMTA-L) cycles continuously, with outcomes automatically feeding back into ML algorithms to determine next experiments. Runs 200-400 experiments per day.
- SeMOpt Algorithm Semantic Memory Enhanced Optimization (SeMOpt) transfer-learning algorithm that accelerates optimization processes by leveraging existing knowledge from past experiments and databases. Automatically identifies key information and guides optimization algorithms to the most promising parameter region from the start, working with any general-purpose Bayesian optimization algorithm.
- Falcon Optimizer Atinary's proprietary machine learning optimizer used for multi-objective optimization, including perovskite solar cell active layer composition and hydroformylation catalysis. Explores multi-dimensional parameter spaces and suggests experimental conditions through iterative optimization campaigns.
Quantifiable outcome
- 5x to 100x reduction in development time and costs compared to DOE and OFAT
- +8 more outcomes
Companies that use Atinary
Customer profileNamed customers11 records
Segments6 records
Ideal customer profiles4 records
Atinary technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability6 records
Feature5 records
Atinary partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core, minor, strategic and flagship.
- ABB RoboticscoreABB Robotics provides GoFa cobots and lab automation technology for Atinary's Self-Driving Labs in Boston. Demonstrated multi-vendor interoperability with instruments from Agilent and Mettler Toledo at SLAS 2026. ABB hosts roundtable on AI and robotics integration in lab operations.
- AgilentcoreAgilent provides laboratory instrumentation integrated into Atinary's Scientific Discovery Factories in Boston. Multi-vendor workflows demonstrated at SLAS 2026 alongside ABB robotics.
- Mettler-ToledocoreMettler-Toledo provides analytical instruments for Atinary's automated lab workflows. Demonstrated in multi-vendor interoperability workflows at SLAS 2026 with ABB robotics.
- ChemspeedcoreChemspeed provides automated synthesis platforms integrated into Atinary's Self-Driving Labs. Longstanding collaboration including joint Demo Lab opening in Basel and published research on automated experimentation.
- BrukercoreBruker provides analytical instrumentation for Atinary's Self-Driving Lab in Boston, part of the integrated autonomous platform for small-molecule synthesis and catalysis.
- InnovaudminorInnovation advisor organization supporting Atinary's participation in Swiss BioTools community and Lausanne ecosystem development.
- Stanford University (Hernández-López Lab)strategicCollaboration with Prof. Rogelio Hernández-López at Stanford to advance T cell engineering using SDLabs for synthetic circuit optimization in CAR-T cell therapy development.
- Snapdragon Chemistry (Cambrex)strategicStrategic collaboration integrating Atinary's SDLabs platform with Snapdragon's LabOSTM software for fully-automated AI-driven Solid-Phase Oligonucleotide Synthesizer. Demonstrated 18% yield increase and 22% cost reduction.
- ACD/LabsstrategicAI-informatics partnership to deliver integrated AI technology for planning, design, and analysis of high throughput and parallel chemistry experiments. First project focused on smart HTE; foundation for smart, automated labs of the future.
- DTU / CAPeXstrategic3-year collaboration with Pioneer Center for Accelerating P2X Materials Discovery at Technical University of Denmark. SDLabs platform to accelerate sustainable materials discovery for Power-to-X applications.
- TakedaflagshipStrategic collaboration with Takeda, the largest Japanese pharmaceutical company. Takeda leverages Atinary's AI Self-Driving Labs technology for drug development. Expanded to include Atinary Lab in Boston for demonstration and co-development.
- AWScoreAtinary joined AWS Partner Network. AWS provides cloud infrastructure for secure, scalable hosting of SDLabs platform and data analytics. Enterprise-grade reliability for customer deployments.
- MIT (Buonassisi Lab)strategicMIT's Buonassisi Lab used SDLabs for perovskite solar cell optimization. Completed 4-week project in 33 experiments that would have taken 2+ years with traditional methods. Prof. Buonassisi called it 'the iPhone of R&D'.
- ViperLabminorCollaboration for perovskite solar cell optimization using SDLabs. Automated search for optimal perovskite layer properties, identifying optimal conditions after 80 samples in 5 iterations.
- MIT (Alexander-Katz Lab)strategicMIT Laboratory for Soft Materials uses Atinary's SDLabs platform to optimize self-assembly in block copolymer thin films for nano-lithography and microelectronics applications.
- dsm-firmenichstrategicCollaboration using Atinary's Falcon ML algorithm and SDLabs platform for hydroformylation R&D optimization. Achieved 10-30x reduction in Rhodium catalyst loading and 95-97% cost reduction. Published in ACS Catalysis 2025.
- JAG GroupstrategicStrategic partnership offering turnkey solution combining Atinary's AI/ML technology with JAG's robotics and automation expertise. Targets pharma, biotech, and clean energy sectors. Strengthens Swiss innovation ecosystem.
- ETH Zurich (SwissCAT+)strategicCollaboration with Swiss national catalysis initiative SwissCAT+ at ETH Zurich. Demonstrated 1000x acceleration in CO2 to methanol catalyst discovery. Joint publication featured on cover of Chem Catalysis. Dr. Paco Laveille leads ETH Catalysis Hub.
- BiopôlecoreBiopôle startup fund recipient. Atinary's Swiss office located at Biopôle life sciences campus in Lausanne. Part of Europe's leading life-science hub ecosystem.
- Solar Impulse FoundationminorSDLabs platform received Solar Impulse Efficient Solution Label for sustainable solutions demonstrating environmental and economic performance.
- IBM Research EuropestrategicCollaboration integrating Atinary's SDLabs platform with IBM's RoboRXN for autonomous chemical reaction optimization. Combines ML and automation for data-driven chemistry. Published results demonstrating 80%+ yield in just 23 experiments.
Scale indicators6 records
Recent moves9 records
Expansion highlights7 records
Atinary competitors and assessment
Company assessmentDirect peers
- Citrine Informatics: AI platform for materials and chemicals R&D that ingests experimental data and optimizes formulations and processes. Directly comparable to Atinary's SDLabs platform in target market (specialty chemicals, advanced materials) and value proposition (faster, cheaper experimentation via ML).
- IBM RoboRXN: IBM's autonomous chemistry platform combining NLP-driven synthesis planning with robotic execution. Direct technical overlap with Atinary's Self-Driving Labs, and IBM is already an active collaborator (chemical reaction optimization published 80%+ yield in 23 experiments), making it both a partner and a potential competitor.
- Chemify: Digital chemistry company building autonomous chemical synthesis platforms using AI-driven code-to-compound workflows. Closely aligned with Atinary's Self-Driving Labs vision in autonomous chemistry execution and serves overlapping pharma/chemicals customers.
- Emerald Cloud Lab: Remote, fully-automated laboratory platform allowing scientists to run experiments via software interfaces. Competes with Atinary in the lab-automation-as-a-service category, though Emerald focuses on broad wet-lab outsourcing while Atinary emphasizes AI-driven autonomous optimization.
- Kebotix: AI and robotics platform for materials discovery targeting chemicals, energy, and consumer products. Directly comparable to Atinary's value proposition of combining ML with automated experimentation to accelerate materials R&D.
- Arctoris: Robotics-as-a-service platform for drug discovery combining automated experimentation with ML-driven analysis. Directly comparable to Atinary's Self-Driving Labs in pharma/biotech R&D automation.
Broad incumbents
- Schrödinger: Public, multi-product computational chemistry and materials science platform serving pharma and industrial R&D. Overlaps with Atinary on AI-driven molecular and materials optimization, but Schrödinger is a broad platform with physics-based simulation plus ML, while Atinary focuses on closed-loop autonomous experimentation.
- Valo Health: AI-driven drug discovery platform combining data, computation, and lab automation across the full preclinical pipeline. Overlaps with Atinary in AI for pharma R&D, though Valo is a vertically integrated drug developer rather than a platform vendor.
Emerging players
- Iktos: AI platform for small molecule drug design focused on generative chemistry and multi-parameter optimization. Comparable in pharmaceutical AI optimization, but Iktos focuses on molecule generation rather than closed-loop lab execution.
Regional players
- BioMap: AI foundation-model platform for biological R&D with strong presence in Asia. Comparable to Atinary in applying large AI models to scientific discovery, though focused on biologics rather than chemistry/materials and concentrated outside of Atinary's core US/European markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Atinary social profiles
Digital presenceAtinary compliance and trust
Trust signalCompliance4 records
Atinary financial estimates
Financial estimateRevenue estimate
Valuation estimate
Atinary leadership team
Management profileNumber of profiles
Profiles3 records
Atinary funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Atinary M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Atinary
What does Atinary do?
Atinary develops and sells the SDLabs AI Platform, a cloud-based no-code software that combines Bayesian optimization machine learning, transfer-learning algorithms (SeMOpt, Falcon), data analytics, and visualization to solve multi-objective optimization problems in chemistry, materials, and pharmaceutical R&D. The company also delivers Self-Driving Labs, a fully integrated autonomous laboratory system combining AI, robotics (ABB, Agilent, Bruker, Chemspeed, Mettler-Toledo), and human expertise to execute closed-loop Design-Make-Test-Analyze-Learn cycles. Customers access the platform via enterprise annual subscriptions, with deployment in under two hours.
Is Atinary a public or private company?
Atinary is a private company. It is classified as venture growth investor backed and is currently operating.
When was Atinary founded?
Atinary was founded in 2019. It employs 11 to 50 people.
Where is Atinary based?
Atinary is headquartered in Lausanne, Switzerland, in the Europe region.
How does Atinary make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are self-Driving Lab Services.
Who are Atinary's main competitors?
Direct peers on record are Citrine Informatics, IBM RoboRXN, Chemify, Emerald Cloud Lab, Kebotix and Arctoris. Broad incumbents are Schrödinger and Valo Health. Iktos is listed as an emerging player. BioMap is listed as a regional player.
Does Atinary have an API?
Yes. Atinary's platform includes API and SDK access available for integration purposes. The platform offers seamless connectivity with robotic hardware and data systems (LIMS, ELNs, etc.), with an agnostic AI platform to enable Self-Driving Labs mode. The platform deploys in under two hours into existing workflows.
What industry is Atinary in?
Atinary's product category is AI-driven R&D platform for chemistry, materials, and pharmaceutical discovery. Its primary akta.pro industry code is HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management), with a secondary code of HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs). Its NAICS code is 513210 and its SIC code is 7372.